Bone marrow-derived mononuclear cell (BMC) therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Bone marrow-derived mononuclear cell (BMC) therapy, covering 2016-05-12 to 2016-05-12. Get the full timeline:
Most recent: Clinical Trial Update: Cell Therapy by Bone Marrow-derived Mononuclear Cells (BMC) for Large Bone Defect Repair: Phase-I Clinical Trial [Phase 1]